"Quinuclidines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
Descriptor ID |
D011812
|
MeSH Number(s) |
D03.605.687
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Quinuclidines".
Below are MeSH descriptors whose meaning is more specific than "Quinuclidines".
This graph shows the total number of publications written about "Quinuclidines" by people in this website by year, and whether "Quinuclidines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2003 | 0 | 1 | 1 |
2007 | 0 | 1 | 1 |
2014 | 1 | 0 | 1 |
2017 | 2 | 0 | 2 |
2018 | 2 | 2 | 4 |
2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Quinuclidines" by people in Profiles.
-
Glucosylceramide synthase inhibitors prevent replication of SARS-CoV-2 and influenza virus. J Biol Chem. 2021 Jan-Jun; 296:100470.
-
The Efficacy and Safety of Once-daily Fluticasone Furoate/Umeclidinium/Vilanterol Versus Twice-daily Budesonide/Formoterol in a Subgroup of Patients from China with Symptomatic COPD at Risk of Exacerbations (FULFIL Trial). COPD. 2018 Jun-Aug; 15(4):334-340.
-
Alcohol-induced conditioned place preference negatively correlates with anxiety-like behavior in adolescent mice: inhibition by a neurokinin-1 receptor antagonist. Psychopharmacology (Berl). 2018 Oct; 235(10):2847-2857.
-
COPD 2017: A Year in Review. COPD. 2018 04; 15(2):118-122.
-
Penehyclidine hydrochloride inhibits TLR4 signaling and inflammation, and attenuates blunt chest trauma and hemorrhagic shock-induced acute lung injury in rats. Mol Med Rep. 2018 05; 17(5):6327-6336.
-
Pharmacological characterization of the interaction between umeclidinium and vilanterol in human bronchi. Eur J Pharmacol. 2017 Oct 05; 812:147-154.
-
Partial agonism at the a7 nicotinic acetylcholine receptor improves attention, impulsive action and vigilance in low attentive rats. Eur Neuropsychopharmacol. 2017 04; 27(4):325-335.
-
Wanted: new treatments for COPD. Lancet Respir Med. 2014 Jun; 2(6):434-6.
-
Recent advances, trends and economic considerations in the risk assessment, prevention and treatment of postoperative nausea and vomiting. Expert Opin Pharmacother. 2007 Dec; 8(18):3217-35.
-
Effects of neurokinins on airway and alveolar eosinophil recruitment. Exp Lung Res. 2003 Apr-May; 29(3):165-77.